🇺🇸 Nevanac in United States

1,034 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Treatment Failure — 219 reports (21.18%)
  2. Drug Ineffective — 211 reports (20.41%)
  3. Vision Blurred — 107 reports (10.35%)
  4. Cataract — 81 reports (7.83%)
  5. Eye Pain — 80 reports (7.74%)
  6. Off Label Use — 78 reports (7.54%)
  7. Visual Acuity Reduced — 75 reports (7.25%)
  8. Visual Impairment — 71 reports (6.87%)
  9. Fatigue — 56 reports (5.42%)
  10. Nausea — 56 reports (5.42%)

Source database →

Nevanac in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in United States

Frequently asked questions

Is Nevanac approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nevanac in United States?

Santa Casa de Misericordia de Santos is the originator. The local marketing authorisation holder may differ — check the official source linked above.